Victory Capital Management Inc. lessened its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 41.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 125,889 shares of the medical technology company’s stock after selling 88,543 shares during the period. Victory Capital Management Inc.’s holdings in Hill-Rom were worth $13,327,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also modified their holdings of the stock. BlackRock Inc. lifted its stake in Hill-Rom by 3.5% in the 4th quarter. BlackRock Inc. now owns 6,350,899 shares of the medical technology company’s stock valued at $562,371,000 after purchasing an additional 215,770 shares during the last quarter. Vanguard Group Inc increased its holdings in shares of Hill-Rom by 0.6% during the third quarter. Vanguard Group Inc now owns 5,916,827 shares of the medical technology company’s stock valued at $558,549,000 after acquiring an additional 34,369 shares in the last quarter. Oregon Public Employees Retirement Fund increased its holdings in shares of Hill-Rom by 8,755.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 2,281,991 shares in the last quarter. Bank of Montreal Can increased its holdings in shares of Hill-Rom by 5.0% during the first quarter. Bank of Montreal Can now owns 1,724,410 shares of the medical technology company’s stock valued at $182,547,000 after acquiring an additional 81,956 shares in the last quarter. Finally, Fisher Asset Management LLC increased its holdings in shares of Hill-Rom by 0.6% during the fourth quarter. Fisher Asset Management LLC now owns 1,313,512 shares of the medical technology company’s stock valued at $116,311,000 after acquiring an additional 7,808 shares in the last quarter. Institutional investors own 84.76% of the company’s stock.
Several brokerages recently weighed in on HRC. Zacks Investment Research downgraded shares of Hill-Rom from a “hold” rating to a “sell” rating in a report on Thursday, February 21st. Needham & Company LLC reiterated a “buy” rating and issued a $116.00 price target on shares of Hill-Rom in a report on Monday, March 11th. ValuEngine downgraded shares of Hill-Rom from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Barclays increased their price target on shares of Hill-Rom from $103.00 to $108.00 and gave the stock an “equal weight” rating in a report on Monday, April 15th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $109.88.
Shares of NYSE HRC traded up $0.85 during midday trading on Tuesday, reaching $96.84. 2,493 shares of the stock were exchanged, compared to its average volume of 524,592. The stock has a market capitalization of $6.41 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.68 and a beta of 0.91. Hill-Rom Holdings, Inc. has a twelve month low of $81.82 and a twelve month high of $108.68. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.69 and a quick ratio of 1.27.
Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, April 26th. The medical technology company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. The business had revenue of $714.20 million for the quarter, compared to analysts’ expectations of $705.59 million. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The business’s revenue was up .5% on a year-over-year basis. During the same quarter last year, the company earned $1.05 EPS. Analysts anticipate that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 21st will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, June 20th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.87%. Hill-Rom’s payout ratio is 17.68%.
TRADEMARK VIOLATION NOTICE: “Victory Capital Management Inc. Cuts Position in Hill-Rom Holdings, Inc. (HRC)” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://transcriptdaily.com/2019/05/21/victory-capital-management-inc-cuts-position-in-hill-rom-holdings-inc-hrc.html.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Article: How Does the Quiet Period Work?
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.